Palvella Therapeutics, Inc. Income Taxes Paid
Palvella Therapeutics, Inc. (PVLA) reported Income Taxes Paid of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2020-03-13
- Palvella Therapeutics, Inc. income taxes paid for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Palvella Therapeutics, Inc. income taxes paid for the quarter ending 2018-12-31 was $6.00K.
- Palvella Therapeutics, Inc. income taxes paid for the quarter ending 2017-12-31 was $0.00.
- Palvella Therapeutics, Inc. income taxes paid for the quarter ending 2015-12-31 was $163.43K.
- Palvella Therapeutics, Inc. income taxes paid for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Palvella Therapeutics, Inc. income taxes paid for fiscal 2018 was $908.00K.
- Palvella Therapeutics, Inc. income taxes paid for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Palvella Therapeutics, Inc. income taxes paid for fiscal 2016 was $162.00K, a 20.54% decline from fiscal 2015.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month | Income Taxes Paid 12 month as first filed |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 10-K · filed 2020-03-13 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $908.00K 10-K · filed 2020-03-13 | ||
| 2018-09-30 | $902.00K 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $0.00 10-K · filed 2019-03-18 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | |||
| 2016-12-31 | $162.00K 10-K · filed 2018-03-15 | $161.97K 10-K · filed 2017-03-30 | ||
| 2015-12-31 | $163.43K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $203.87K 10-K · filed 2017-03-30 | ||
| 2015-09-30 | $40.44K 10-Q · filed 2016-11-10 | |||
| 2013-09-30 | $0.00 10-Q · filed 2014-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |